NCT04283669
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04283669
Title Phase 2 Clinical Trial of Crizotinib for Children and Adults with Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas (NF110)
Acronym NF110
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Alabama at Birmingham
Indications
Therapies
Age Groups: child | adult | senior
Covered Countries USA

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field